Back to Course

2025 PACUPrep BCCCP Preparatory Course

0% Complete
0/0 Steps
  1. Pulmonary

    ARDS
    4 Topics
    |
    1 Quiz
  2. Asthma Exacerbation
    4 Topics
    |
    1 Quiz
  3. COPD Exacerbation
    4 Topics
    |
    1 Quiz
  4. Cystic Fibrosis
    6 Topics
    |
    1 Quiz
  5. Drug-Induced Pulmonary Diseases
    3 Topics
    |
    1 Quiz
  6. Mechanical Ventilation Pharmacotherapy
    5 Topics
    |
    1 Quiz
  7. Pleural Disorders
    5 Topics
    |
    1 Quiz
  8. Pulmonary Hypertension (Acute and Chronic severe pulmonary hypertension)
    5 Topics
    |
    1 Quiz
  9. Cardiology
    Acute Coronary Syndromes
    6 Topics
    |
    1 Quiz
  10. Atrial Fibrillation and Flutter
    6 Topics
    |
    1 Quiz
  11. Cardiogenic Shock
    4 Topics
    |
    1 Quiz
  12. Heart Failure
    7 Topics
    |
    1 Quiz
  13. Hypertensive Crises
    5 Topics
    |
    1 Quiz
  14. Ventricular Arrhythmias and Sudden Cardiac Death Prevention
    5 Topics
    |
    1 Quiz
  15. NEPHROLOGY
    Acute Kidney Injury (AKI)
    5 Topics
    |
    1 Quiz
  16. Contrast‐Induced Nephropathy
    5 Topics
    |
    1 Quiz
  17. Drug‐Induced Kidney Diseases
    5 Topics
    |
    1 Quiz
  18. Rhabdomyolysis
    5 Topics
    |
    1 Quiz
  19. Syndrome of Inappropriate Antidiuretic Hormone (SIADH)
    5 Topics
    |
    1 Quiz
  20. Renal Replacement Therapies (RRT)
    5 Topics
    |
    1 Quiz
  21. Neurology
    Status Epilepticus
    5 Topics
    |
    1 Quiz
  22. Acute Ischemic Stroke
    5 Topics
    |
    1 Quiz
  23. Subarachnoid Hemorrhage
    5 Topics
    |
    1 Quiz
  24. Spontaneous Intracerebral Hemorrhage
    5 Topics
    |
    1 Quiz
  25. Neuromonitoring Techniques
    5 Topics
    |
    1 Quiz
  26. Gastroenterology
    Acute Upper Gastrointestinal Bleeding
    5 Topics
    |
    1 Quiz
  27. Acute Lower Gastrointestinal Bleeding
    5 Topics
    |
    1 Quiz
  28. Acute Pancreatitis
    5 Topics
    |
    1 Quiz
  29. Enterocutaneous and Enteroatmospheric Fistulas
    5 Topics
    |
    1 Quiz
  30. Ileus and Acute Intestinal Pseudo-obstruction
    5 Topics
    |
    1 Quiz
  31. Abdominal Compartment Syndrome
    5 Topics
    |
    1 Quiz
  32. Hepatology
    Acute Liver Failure
    5 Topics
    |
    1 Quiz
  33. Portal Hypertension & Variceal Hemorrhage
    5 Topics
    |
    1 Quiz
  34. Hepatic Encephalopathy
    5 Topics
    |
    1 Quiz
  35. Ascites & Spontaneous Bacterial Peritonitis
    5 Topics
    |
    1 Quiz
  36. Hepatorenal Syndrome
    5 Topics
    |
    1 Quiz
  37. Drug-Induced Liver Injury
    5 Topics
    |
    1 Quiz
  38. Dermatology
    Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis
    5 Topics
    |
    1 Quiz
  39. Erythema multiforme
    5 Topics
    |
    1 Quiz
  40. Drug Reaction (or Rash) with Eosinophilia and Systemic Symptoms (DRESS)
    5 Topics
    |
    1 Quiz
  41. Immunology
    Transplant Immunology & Acute Rejection
    5 Topics
    |
    1 Quiz
  42. Solid Organ & Hematopoietic Transplant Pharmacotherapy
    5 Topics
    |
    1 Quiz
  43. Graft-Versus-Host Disease (GVHD)
    5 Topics
    |
    1 Quiz
  44. Hypersensitivity Reactions & Desensitization
    5 Topics
    |
    1 Quiz
  45. Biologic Immunotherapies & Cytokine Release Syndrome
    5 Topics
    |
    1 Quiz
  46. Endocrinology
    Relative Adrenal Insufficiency and Stress-Dose Steroid Therapy
    5 Topics
    |
    1 Quiz
  47. Hyperglycemic Crisis (DKA & HHS)
    5 Topics
    |
    1 Quiz
  48. Glycemic Control in the ICU
    5 Topics
    |
    1 Quiz
  49. Thyroid Emergencies: Thyroid Storm & Myxedema Coma
    5 Topics
    |
    1 Quiz
  50. Hematology
    Acute Venous Thromboembolism
    5 Topics
    |
    1 Quiz
  51. Drug-Induced Thrombocytopenia
    5 Topics
    |
    1 Quiz
  52. Anemia of Critical Illness
    5 Topics
    |
    1 Quiz
  53. Drug-Induced Hematologic Disorders
    5 Topics
    |
    1 Quiz
  54. Sickle Cell Crisis in the ICU
    5 Topics
    |
    1 Quiz
  55. Methemoglobinemia & Dyshemoglobinemias
    5 Topics
    |
    1 Quiz
  56. Toxicology
    Toxidrome Recognition and Initial Management
    5 Topics
    |
    1 Quiz
  57. Management of Acute Overdoses – Non-Cardiovascular Agents
    5 Topics
    |
    1 Quiz
  58. Management of Acute Overdoses – Cardiovascular Agents
    5 Topics
    |
    1 Quiz
  59. Toxic Alcohols and Small-Molecule Poisons
    5 Topics
    |
    1 Quiz
  60. Antidotes and Gastrointestinal Decontamination
    5 Topics
    |
    1 Quiz
  61. Extracorporeal Removal Techniques
    5 Topics
    |
    1 Quiz
  62. Withdrawal Syndromes in the ICU
    5 Topics
    |
    1 Quiz
  63. Infectious Diseases
    Sepsis and Septic Shock
    5 Topics
    |
    1 Quiz
  64. Pneumonia (CAP, HAP, VAP)
    5 Topics
    |
    1 Quiz
  65. Endocarditis
    5 Topics
    |
    1 Quiz
  66. CNS Infections
    5 Topics
    |
    1 Quiz
  67. Complicated Intra-abdominal Infections
    5 Topics
    |
    1 Quiz
  68. Antibiotic Stewardship & PK/PD
    5 Topics
    |
    1 Quiz
  69. Clostridioides difficile Infection
    5 Topics
    |
    1 Quiz
  70. Febrile Neutropenia & Immunocompromised Hosts
    5 Topics
    |
    1 Quiz
  71. Skin & Soft-Tissue Infections / Acute Osteomyelitis
    5 Topics
    |
    1 Quiz
  72. Urinary Tract and Catheter-related Infections
    5 Topics
    |
    1 Quiz
  73. Pandemic & Emerging Viral Infections
    5 Topics
    |
    1 Quiz
  74. Supportive Care (Pain, Agitation, Delirium, Immobility, Sleep)
    Pain Assessment and Analgesic Management
    5 Topics
    |
    1 Quiz
  75. Sedation and Agitation Management
    5 Topics
    |
    1 Quiz
  76. Delirium Prevention and Treatment
    5 Topics
    |
    1 Quiz
  77. Sleep Disturbance Management
    5 Topics
    |
    1 Quiz
  78. Immobility and Early Mobilization
    5 Topics
    |
    1 Quiz
  79. Oncologic Emergencies
    5 Topics
    |
    1 Quiz
  80. End-of-Life Care & Palliative Care
    Goals of Care & Advance Care Planning
    5 Topics
    |
    1 Quiz
  81. Pain Management & Opioid Therapy
    5 Topics
    |
    1 Quiz
  82. Dyspnea & Respiratory Symptom Management
    5 Topics
    |
    1 Quiz
  83. Sedation & Palliative Sedation
    5 Topics
    |
    1 Quiz
  84. Delirium Agitation & Anxiety
    5 Topics
    |
    1 Quiz
  85. Nausea, Vomiting & Gastrointestinal Symptoms
    5 Topics
    |
    1 Quiz
  86. Management of Secretions (Death Rattle)
    5 Topics
    |
    1 Quiz
  87. Fluids, Electrolytes, and Nutrition Management
    Intravenous Fluid Therapy and Resuscitation
    5 Topics
    |
    1 Quiz
  88. Acid–Base Disorders
    5 Topics
    |
    1 Quiz
  89. Sodium Homeostasis and Dysnatremias
    5 Topics
    |
    1 Quiz
  90. Potassium Disorders
    5 Topics
    |
    1 Quiz
  91. Calcium and Magnesium Abnormalities
    5 Topics
    |
    1 Quiz
  92. Phosphate and Trace Electrolyte Management
    5 Topics
    |
    1 Quiz
  93. Enteral Nutrition Support
    5 Topics
    |
    1 Quiz
  94. Parenteral Nutrition Support
    5 Topics
    |
    1 Quiz
  95. Refeeding Syndrome and Specialized Nutrition
    5 Topics
    |
    1 Quiz
  96. Trauma and Burns
    Initial Resuscitation and Fluid Management in Trauma
    5 Topics
    |
    1 Quiz
  97. Hemorrhagic Shock, Massive Transfusion, and Trauma‐Induced Coagulopathy
    5 Topics
    |
    1 Quiz
  98. Burns Pharmacotherapy
    5 Topics
    |
    1 Quiz
  99. Burn Wound Care
    5 Topics
    |
    1 Quiz
  100. Open Fracture Antibiotics
    5 Topics
    |
    1 Quiz

Participants 432

  • Allison Clemens
  • April
  • ababaabhay
  • achoi2392
  • adhoward1
Show more
Lesson Progress
0% Complete
Diagnosis and Severity Stratification of Thyroid Emergencies

Diagnosis and Severity Stratification of Thyroid Emergencies

Objective Icon A checkmark inside a circle, symbolizing an achieved goal.

Objective

Apply diagnostic and classification criteria to assess thyroid storm and myxedema coma and direct initial management.

1. Clinical Assessment

Distinguishing the hypermetabolic state of thyroid storm from the hypometabolic state of myxedema coma requires a systematic evaluation of vital signs, mental status, and multi-organ findings. These two conditions represent opposite ends of the thyroid function spectrum, yet both are life-threatening emergencies.

A. Vital Signs

  • Temperature: A hallmark differentiator. Thyroid storm typically presents with significant hyperthermia (>38.5°C), while myxedema coma is characterized by profound hypothermia (<35°C).
  • Heart Rate: Tachycardia, often exceeding 140 bpm or presenting as atrial fibrillation, is classic for thyroid storm. In contrast, myxedema coma features marked bradycardia (<60 bpm).
  • Blood Pressure: Hemodynamics are dynamic. Thyroid storm may begin with labile hypertension but can progress to refractory hypotension in decompensated states. Myxedema coma consistently presents with hypotension.

B. Neurologic Status

  • Thyroid Storm: Patients often exhibit severe central nervous system (CNS) hyper-excitability, including agitation, delirium, psychosis, or seizures.
  • Myxedema Coma: The neurologic exam reveals profound CNS depression, ranging from lethargy and stupor to frank coma. The Glasgow Coma Scale is a critical tool to assess the need for definitive airway management.

C. Organ System Findings

  • Gastrointestinal (GI): Thyroid storm manifests with hypermotility (diarrhea, nausea, vomiting) and can lead to hepatic dysfunction. Myxedema coma causes hypomotility, leading to constipation or paralytic ileus, and is associated with marked elevation in creatine kinase (CK) from myopathy.
  • Cardiopulmonary: High-output heart failure and pulmonary edema are common in thyroid storm. Myxedema coma can cause hypoventilation, pleural effusions, and pericardial effusions.

Case Vignette: A 52-year-old woman with a history of Graves’ disease presents to the emergency department with a fever of 40°C, a heart rate of 150 bpm in atrial fibrillation, severe agitation, and profuse diarrhea. Her Burch-Wartofsky Point Scale (BWPS) score is calculated to be 55, prompting immediate transfer to the intensive care unit (ICU) and initiation of treatment for thyroid storm.

Pearl Icon A shield with an exclamation mark, indicating a clinical pearl. Key Clinical Pearls +
  • Early, marked tachycardia (heart rate >140 bpm), especially when disproportionate to fever, may be the first and most prominent clue to developing thyroid storm.
  • In elderly or frail patients, the profound hypothermia of myxedema coma may be masked, presenting as a “normal” or only slightly low temperature. A lack of fever in the setting of a clear infection should raise high suspicion.

2. Laboratory Evaluation

Rapid laboratory analysis is crucial to confirm thyroid hormone derangements, identify potential precipitating factors, and detect critical metabolic complications, such as adrenal insufficiency.

A. Thyroid Function Tests (TFTs)

  • Thyroid Storm: Characterized by a suppressed Thyroid-Stimulating Hormone (TSH) and elevated free thyroxine (T4) and free triiodothyronine (T3). The degree of free T3 elevation often correlates best with the clinical severity of the storm.
  • Myxedema Coma: The classic pattern is a markedly elevated TSH with low free T4 and T3. However, TFTs must be interpreted cautiously in critically ill patients, as “euthyroid sick syndrome” can mimic these findings.

B. Adrenal Assessment

  • A random cortisol level should be drawn immediately. A level <10 µg/dL is highly suggestive of relative adrenal insufficiency, a common concurrent finding.
  • An ACTH level can be obtained for later diagnostic workup, but treatment with empiric hydrocortisone should never be delayed while awaiting results.

C. Metabolic Panels

  • Electrolytes: Hyponatremia is a common and significant finding in myxedema coma due to impaired free water excretion.
  • Glucose: Hypoglycemia can occur in myxedema coma due to impaired gluconeogenesis and is a marker of severe metabolic collapse. Glucose levels should be monitored closely.
  • Liver Function Tests (LFTs) and Creatine Kinase (CK): Mild transaminitis can be seen in thyroid storm due to hepatic congestion and hypermetabolism. In contrast, a marked CK elevation is characteristic of the myopathy in myxedema coma.
Pearl IconA shield with an exclamation mark, indicating a clinical pearl. Key Clinical Pearls +
  • A disproportionately high free T3 level compared to free T4 in a thyrotoxic patient may indicate a more severe storm and warrants earlier, more aggressive beta-blockade.
  • The hyponatremia of myxedema coma reflects excess water retention, not sodium depletion. It should be corrected slowly with fluid restriction and thyroid hormone replacement to avoid osmotic demyelination syndrome.

3. Advanced Diagnostics

Electrocardiography (ECG) and imaging studies are essential to assess the end-organ impact of the thyroid emergency, identify complications, and guide the intensity of monitoring.

A. Electrocardiogram (ECG)

  • Thyroid Storm: Common findings include sinus tachycardia, new-onset atrial fibrillation with a rapid ventricular response, and occasionally a shortened QTc interval.
  • Myxedema Coma: The ECG typically shows sinus bradycardia, low voltage QRS complexes (due to myxedema and/or pericardial effusion), and a prolonged QTc interval, which creates a significant risk for torsades de pointes.

B. Imaging

  • Chest X-Ray: Can reveal signs of heart failure such as pulmonary edema and cardiomegaly in both conditions. Pleural effusions are also common, particularly in myxedema coma.
  • Echocardiography: This is a key diagnostic tool. In thyroid storm, it may show a hyperdynamic ventricle and signs of high-output heart failure. In myxedema coma, it can reveal global hypokinesis, diastolic dysfunction, and the presence of a pericardial effusion, which can progress to tamponade.
Pearl IconA shield with an exclamation mark, indicating a clinical pearl. Key Clinical Pearls +
  • Continuous telemetry is mandatory for both conditions. Subtle changes in the QTc interval, especially in myxedema coma, can herald impending life-threatening arrhythmias.
  • An early bedside echocardiogram is invaluable. It can rapidly differentiate between high-output failure needing afterload reduction (storm) and global hypokinesis needing inotropic support (coma), fundamentally altering the initial resuscitation strategy.

4. Severity Scoring Systems

Validated scoring systems are critical tools that translate a constellation of clinical and laboratory findings into objective, actionable categories that guide triage and define urgency.

A. Burch–Wartofsky Point Scale (BWPS) for Thyroid Storm

The BWPS is the most widely used tool for diagnosing and quantifying the severity of thyroid storm. Points are assigned across several domains, with a higher score indicating a greater likelihood and severity of storm.

Burch–Wartofsky Point Scale (BWPS) Summary
Domain Maximum Points
Thermoregulatory Dysfunction (Temperature) 30
Central Nervous System (CNS) Effects 30
Gastrointestinal/Hepatic Dysfunction 20
Cardiovascular Dysfunction (Heart Rate, AF, CHF) 30
Presence of a Precipitating Event 10
Interpretation:
  • Total Score ≥45: Highly suggestive of thyroid storm.
  • Total Score 25–44: Suggests impending storm; requires close monitoring and aggressive treatment.
  • Total Score <25: Thyroid storm is unlikely.

B. Myxedema Coma Score (Popoveniuc et al.)

A similar scoring system exists for myxedema coma, incorporating key parameters of hypometabolism and organ dysfunction.

  • Core Components: Temperature, CNS status, GI symptoms, cardiovascular hemodynamics, metabolic disturbances (hyponatremia, hypoglycemia), and the presence of precipitating factors.
  • Interpretation:
    • Score ≥60: Diagnostic of myxedema coma.
    • Score 25–59: Indicates impending decompensation.
    • Score <25: Myxedema coma is unlikely.

Editor’s Note: Detailed point assignments for each myxedema coma score component are not provided here due to limited source details. A complete version should include specific point values for temperature ranges, levels of consciousness, severity of GI findings, hemodynamic parameters, and degree of metabolic disturbances.

Pearl IconA shield with an exclamation mark, indicating a clinical pearl. Key Clinical Pearls +
  • In patients with a high pre-test probability and a high score (BWPS ≥45 or Myxedema Score ≥60), do not await laboratory confirmation. Initiate life-saving treatment immediately based on the clinical diagnosis.
  • Scoring thresholds are not just diagnostic; they are practical guides for resource allocation. A score in the “impending” range (e.g., BWPS 25-44) warrants admission to a high-dependency unit, while a score in the “overt” range (e.g., BWPS ≥45) mandates ICU-level care.

5. Integration into a Clinical Pathway

Severity scores are the cornerstone of a modern clinical pathway for thyroid emergencies. They inform triage decisions, dictate monitoring intensity, and trigger time-sensitive interventions.

A. Triage and Monitoring

  • ICU Admission: Patients with a BWPS ≥45 or a myxedema coma score ≥60 require immediate ICU admission for invasive hemodynamic monitoring (e.g., arterial line), continuous cardiac monitoring, and potential mechanical ventilation.
  • High-Dependency/Step-Down Unit: Patients in the “impending” range (BWPS 25–44 or coma score 25–59) should be managed in a high-dependency setting with continuous telemetry and frequent reassessment.

B. Immediate Intervention Algorithm

Once a thyroid emergency is suspected, a standardized, parallel set of interventions should be initiated.

Thyroid Emergency Intervention Algorithm A flowchart showing the immediate steps for managing a thyroid emergency. It starts with securing the airway, then branches to specific treatments for thyroid storm (cooling, beta-blockade, antithyroid drugs) and myxedema coma (rewarming, thyroid replacement), with both pathways including empiric hydrocortisone and treatment of precipitating factors. 1. Secure Airway (if AMS) 2. Empiric Hydrocortisone Thyroid Storm 3a. Aggressive Cooling 4a. Beta-Blockade (Esmolol) 5a. Antithyroid Therapy (PTU/MMI) Myxedema Coma 3b. Cautious Passive Rewarming 4b. IV Thyroid Replacement (Levothyroxine +/- Liothyronine) 6. Treat Precipitating Factors
Figure 1: Immediate Intervention Pathway for Thyroid Emergencies. This algorithm highlights the critical initial steps, including universal interventions like airway support and empiric steroids, followed by diagnosis-specific therapies.
Pearl IconA shield with an exclamation mark, indicating a clinical pearl. Key Clinical Pearls +
  • Embedding these scoring tools and intervention algorithms directly into electronic health record (EHR) order sets can significantly reduce time-to-therapy and improve adherence to best practices.
  • Early multidisciplinary collaboration is key. A “thyroid emergency response team” involving critical care, endocrinology, and clinical pharmacy ensures all aspects of these complex conditions are managed optimally from the outset.

References

  1. Burch HB, Wartofsky L. Life-threatening hyperthyroidism: thyroid storm. Endocrinol Metab Clin North Am. 1993;22(2):263–277.
  2. Popoveniuc G, Sud A, Wassner AJ, et al. Diagnostic scoring system and management guidelines for myxedema coma. Endocr Pract. 2014;20(8):808–817.
  3. Bahn RS, Burch HB, Cooper DS, et al. Hyperthyroidism and other causes of thyrotoxicosis: management guidelines. Thyroid. 2011;21(6):593–646.
  4. Leung AM. Thyroid Emergencies. J Infus Nurs. 2016;39(5):281–286.
  5. Wall CR. Myxedema Coma: Diagnosis and Treatment. Am Fam Physician. 2000;62(11):2485–2490.